| Year |
Citation |
Score |
| 2015 |
Freeman ZT, Rice KA, Soto PL, Pate KA, Weed MR, Ator NA, DeLeon IG, Wong DF, Zhou Y, Mankowski JL, Zink MC, Adams RJ, Hutchinson EK. Neurocognitive dysfunction and pharmacological intervention using guanfacine in a rhesus macaque model of self-injurious behavior. Translational Psychiatry. 5: e567. PMID 25989141 DOI: 10.1038/Tp.2015.61 |
0.64 |
|
| 2013 |
Soto PL, Ator NA, Rallapalli SK, Biawat P, Clayton T, Cook JM, Weed MR. Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected]. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2315-25. PMID 23722241 DOI: 10.1038/Npp.2013.137 |
0.629 |
|
| 2013 |
Soto PL, Dallery J, Ator NA, Katz BR. A critical examination of best dose analysis for determining cognitive-enhancing potential of drugs: studies with rhesus monkeys and computer simulations. Psychopharmacology. 228: 611-22. PMID 23529381 DOI: 10.1007/S00213-013-3070-4 |
0.324 |
|
| 2013 |
Goodwin AK, Mueller M, Shell CD, Ricaurte GA, Ator NA. Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons. The Journal of Pharmacology and Experimental Therapeutics. 345: 342-53. PMID 23516331 DOI: 10.1124/Jpet.113.203729 |
0.407 |
|
| 2013 |
Soto PL, Ator NA, Rallapalli SK, Biawat P, Clayton T, Cook JM, Weed MR. Erratum: Allosteric Modulation of GABAA Receptor Subtypes: Effects on Visual Recognition and Visuospatial Working Memory in Rhesus Monkeys Neuropsychopharmacology. 38: 2553-2553. DOI: 10.1038/Npp.2013.162 |
0.609 |
|
| 2013 |
Soto PL, Wilcox KM, Zhou Y, Ator NA, Riddle MA, Wong DF, Weed MR. Erratum: Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: Effects on physiology, behavior, and dopamine system development (Neuropsychopharmacology (2013) 38 (1141) DOI: 10.1038/npp.2013.15) Neuropsychopharmacology. 38. DOI: 10.1038/Npp.2013.15 |
0.636 |
|
| 2012 |
Soto PL, Wilcox KM, Zhou Y, Kumar A, Ator NA, Riddle MA, Wong DF, Weed MR. Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2566-79. PMID 22805599 DOI: 10.1038/Npp.2012.119 |
0.652 |
|
| 2011 |
Mueller M, Goodwin AK, Ator NA, McCann UD, Ricaurte GA. Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences. The Journal of Pharmacology and Experimental Therapeutics. 338: 310-7. PMID 21493752 DOI: 10.1124/Jpet.111.180612 |
0.326 |
|
| 2011 |
Goodwin AK, Kaminski BJ, Griffiths RR, Ator NA, Weerts EM. Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons. Drug and Alcohol Dependence. 114: 217-24. PMID 21112162 DOI: 10.1016/J.Drugalcdep.2010.10.006 |
0.394 |
|
| 2010 |
Ator NA, Atack JR, Hargreaves RJ, Burns HD, Dawson GR. Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at α1 and α2/3 subtypes Journal of Pharmacology and Experimental Therapeutics. 332: 4-16. PMID 19789360 DOI: 10.1124/Jpet.109.158303 |
0.344 |
|
| 2008 |
Weed MR, Wilcox KM, Ator NA, Hienz RD. Consistent, high-level ethanol consumption in pig-tailed macaques via a multiple-session, limited-intake, oral self-dosing procedure. Alcoholism, Clinical and Experimental Research. 32: 942-51. PMID 18445107 DOI: 10.1111/J.1530-0277.2008.00652.X |
0.705 |
|
| 2008 |
Kohut SJ, Ator NA. Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023. Pharmacology, Biochemistry, and Behavior. 90: 65-73. PMID 18395780 DOI: 10.1016/J.Pbb.2008.02.019 |
0.337 |
|
| 2006 |
Weed MR, Carruth LM, Adams RJ, Ator NA, Hienz RD. Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 250-9. PMID 18040802 DOI: 10.1007/S11481-006-9029-Z |
0.691 |
|
| 2005 |
Weerts EM, Ator NA, Kaminski BJ, Griffiths RR. Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons. European Journal of Pharmacology. 519: 103-13. PMID 16129429 DOI: 10.1016/J.Ejphar.2005.06.038 |
0.4 |
|
| 2005 |
Ator NA, Griffiths RR, Weerts EM. Self-injection of flunitrazepam alone and in the context of methadone maintenance in baboons. Drug and Alcohol Dependence. 78: 113-23. PMID 15845314 DOI: 10.1016/J.Drugalcdep.2004.09.007 |
0.352 |
|
| 2005 |
Ator NA. Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders. Cns Spectrums. 10: 31-9. PMID 15618945 DOI: 10.1017/S1092852900009883 |
0.31 |
|
| 2003 |
Ator NA. Selectivity in generalization to GABAergic drugs in midazolam-trained baboons. Pharmacology, Biochemistry, and Behavior. 75: 435-45. PMID 12873636 DOI: 10.1016/S0091-3057(03)00135-7 |
0.369 |
|
| 2003 |
Ator NA, Griffiths RR. Principles of drug abuse liability assessment in laboratory animals. Drug and Alcohol Dependence. 70: S55-72. PMID 12759197 DOI: 10.1016/S0376-8716(03)00099-1 |
0.401 |
|
| 2003 |
Griffiths RR, Bigelow GE, Ator NA. Principles of initial experimental drug abuse liability assessment in humans. Drug and Alcohol Dependence. 70: S41-54. PMID 12759196 DOI: 10.1016/S0376-8716(03)00098-X |
0.373 |
|
| 2002 |
Ator NA. Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons. Psychopharmacology. 163: 477-87. PMID 12373448 DOI: 10.1007/S00213-002-1076-4 |
0.377 |
|
| 2001 |
Kaminski BJ, Ator NA. Behavioral and pharmacological variables affecting risky choice in rats Journal of the Experimental Analysis of Behavior. 75: 275-297. PMID 11453619 DOI: 10.1901/Jeab.2001.75-275 |
0.371 |
|
| 2000 |
Zarcone TJ, Ator NA. Drug discrimination: stimulus control during repeated testing in extinction. Journal of the Experimental Analysis of Behavior. 74: 283-94. PMID 11218226 DOI: 10.1901/Jeab.2000.74-283 |
0.354 |
|
| 2000 |
Ator NA, Weerts EM, Kaminski BJ, Kautz MA, Griffiths RR. Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Drug and Alcohol Dependence. 61: 69-84. PMID 11064185 DOI: 10.1016/S0376-8716(00)00122-8 |
0.353 |
|
| 2000 |
Ator NA. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons. Drug and Alcohol Dependence. 61: 55-68. PMID 11064184 DOI: 10.1016/S0376-8716(00)00123-X |
0.389 |
|
| 2000 |
Ator NA, Kautz MA. Differentiating benzodiazepine- and barbiturate-like discriminative stimulus effects of lorazepam, diazepam, pentobarbital, imidazenil and zaleplon in two- versus three-lever procedures. Behavioural Pharmacology. 11: 1-14. PMID 10821204 DOI: 10.1097/00008877-200002000-00001 |
0.344 |
|
| 1999 |
Weerts EM, Ator NA, Griffiths RR. Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. Drug and Alcohol Dependence. 57: 51-60. PMID 10617313 DOI: 10.1016/S0376-8716(99)00044-7 |
0.38 |
|
| 1999 |
Ator NA. High-dose discrimination training with midazolam: context determines generalization profile. Pharmacology, Biochemistry, and Behavior. 64: 237-43. PMID 10515297 DOI: 10.1016/S0091-3057(99)00050-7 |
0.356 |
|
| 1995 |
Kautz MA, Ator NA. Effects of triazolam on drinking in baboons with and without an oral self-administration history: a reinstatement phenomenon. Psychopharmacology. 122: 108-14. PMID 8848525 DOI: 10.1007/Bf02246084 |
0.42 |
|
| 1994 |
Sanreud CA, Ator NA. Evaluation of the discriminative stimulus effects of two midazolam doses Pharmacology Biochemistry and Behavior. 48: 835. DOI: 10.1016/0091-3057(94)90395-6 |
0.304 |
|
| 1994 |
Ator NA. Benzodiazepines and beyond: Reinforcement, discrimination and dependence Pharmacology Biochemistry and Behavior. 48: 825. DOI: 10.1016/0091-3057(94)90360-3 |
0.316 |
|
| 1993 |
Sannerud CA, Ator NA, Griffiths RR. Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discrimination. Drug and Alcohol Dependence. 32: 195-208. PMID 8102330 DOI: 10.1016/0376-8716(93)90084-4 |
0.431 |
|
| 1993 |
Sannerud CA, Ator NA, Griffiths RR. Behavioral pharmacology of abecarnil in baboons: reduced dependence and abuse potential. Psychopharmacology Series. 11: 113-20. PMID 7908430 DOI: 10.1007/978-3-642-78451-4_9 |
0.349 |
|
| 1993 |
Ator NA, Grant KA, Purdy RH, Paul SM, Griffiths RR. Drug discrimination analysis of endogenous neuroactive steroids in rats. European Journal of Pharmacology. 241: 237-43. PMID 7902289 DOI: 10.1016/0014-2999(93)90208-Y |
0.328 |
|
| 1993 |
Ator NA, Griffiths RR. Differential sensitivity to midazolam discriminative-stimulus effects following self-administered versus response-independent midazolam. Psychopharmacology. 110: 1-4. PMID 7870866 DOI: 10.1007/Bf02246943 |
0.399 |
|
| 1992 |
Sannerud CA, Ator NA, Griffiths RR. Behavioral pharmacology of abecarnil in baboons: self-injection, drug discrimination and physical dependence. Behavioural Pharmacology. 3: 507-516. PMID 11224153 DOI: 10.1097/00008877-199210000-00009 |
0.415 |
|
| 1992 |
Ator NA, Griffiths RR. Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence. Psychopharmacology. 108: 301-12. PMID 1523281 DOI: 10.1007/Bf02245116 |
0.43 |
|
| 1992 |
Griffiths RR, Sannerud CA, Ator NA, Brady JV. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 260: 1199-208. PMID 1312162 |
0.327 |
|
| 1991 |
Sannerud CA, Ator NA, Griffiths RR. Methocarbamol: evaluation of reinforcing and discriminative stimulus effects. Behavioural Pharmacology. 2: 143-150. PMID 11224058 |
0.302 |
|
| 1991 |
Griffiths RR, Lamb RJ, Sannerud CA, Ator NA, Brady JV. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacology. 103: 154-61. PMID 1674158 DOI: 10.1007/Bf02244196 |
0.347 |
|
| 1991 |
Sannerud CA, Ator NA, Griffiths RR. Comparison of the discriminative stimulus effects of midazolam after intracranial and peripheral administration in the rat. Life Sciences. 49: 261-8. PMID 1649362 DOI: 10.1016/0024-3205(91)90012-Z |
0.37 |
|
| 1991 |
Ator NA. Drug reinforcement and drug discrimination with benzodiazepines in the baboon Pharmacology Biochemistry and Behavior. 39: 232. DOI: 10.1016/0091-3057(91)90461-A |
0.327 |
|
| 1990 |
Nierenberg J, Ator NA. Drug discrimination in rats successively trained to discriminate diazepam and pentobarbital. Pharmacology, Biochemistry, and Behavior. 35: 405-12. PMID 2320649 DOI: 10.1016/0091-3057(90)90177-J |
0.304 |
|
| 1990 |
Brady JV, Hienz RD, Ator NA. Stimulus functions of drugs and the assessment of abuse liability Drug Development Research. 20: 231-249. DOI: 10.1002/Ddr.430200209 |
0.628 |
|
| 1990 |
Ator NA. Drug discrimination and drug stimulus generalization with anxiolytics Drug Development Research. 20: 189-204. DOI: 10.1002/Ddr.430200206 |
0.381 |
|
| 1989 |
Hienz RD, Brady JV, Bowers DA, Ator NA. Ethanol's effects on auditory thresholds and reaction times during the acquisition of chronic ethanol self-administration in baboons. Drug and Alcohol Dependence. 24: 213-25. PMID 2605997 DOI: 10.1016/0376-8716(89)90058-6 |
0.606 |
|
| 1989 |
Ator NA, Griffiths RR. Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam. Psychopharmacology. 98: 20-30. PMID 2567033 DOI: 10.1007/Bf00442001 |
0.338 |
|
| 1989 |
Ator NA, Griffiths RR. Asymmetrical cross-generalization in drug discrimination with lorazepam and pentobarbital training conditions Drug Development Research. 16: 355-364. DOI: 10.1002/Ddr.430160229 |
0.333 |
|
| 1989 |
Ator NA, Cook JM, Griffiths RR. Drug discrimination in pentylenetetrazol-trained baboons: Generalization to buspirone and ?-carboline-3-carboxylic acid ethyl ester but not lorazepam or pentobarbital Drug Development Research. 16: 257-267. DOI: 10.1002/Ddr.430160219 |
0.358 |
|
| 1987 |
Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of triazolam: experimental measurements in animals and humans. Psychopharmacology Series. 3: 83-7. PMID 3823094 DOI: 10.1007/978-3-642-71288-3_10 |
0.355 |
|
| 1987 |
Ator NA, Griffiths RR. Self-administration of barbiturates and benzodiazepines: a review. Pharmacology, Biochemistry, and Behavior. 27: 391-8. PMID 2888136 DOI: 10.1016/0091-3057(87)90588-0 |
0.399 |
|
| 1985 |
Ator NA, Griffiths RR. Lorazepam and pentobarbital discrimination: interactions with CGS 8216 and caffeine. European Journal of Pharmacology. 107: 169-81. PMID 3979425 DOI: 10.1016/0014-2999(85)90056-1 |
0.384 |
|
| 1985 |
Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV. Relative abuse liability of triazolam: experimental assessment in animals and humans. Neuroscience and Biobehavioral Reviews. 9: 133-51. PMID 2858078 DOI: 10.1016/0149-7634(85)90039-9 |
0.409 |
|
| 1984 |
Brady JV, Griffiths RR, Hienz RD, Bigelow GE, Emurian HH, Lukas SE, Ator NA, Nellis MJ, Ray RL, Pearlson GD. Abuse liability and behavioral toxicity assessment: progress report from the behavioral biology laboratories of the Johns Hopkins University School of Medicine. Nida Research Monograph. 49: 92-108. PMID 6148698 |
0.55 |
|
| 1983 |
Ator NA, Griffiths RR. Nicotine self-administration in baboons. Pharmacology, Biochemistry, and Behavior. 19: 993-1003. PMID 6657733 DOI: 10.1016/0091-3057(83)90406-9 |
0.374 |
|
| 1983 |
Ator NA, Griffiths RR. Oral self-administration of methohexital in baboons. Psychopharmacology. 79: 120-5. PMID 6405419 DOI: 10.1007/Bf00427797 |
0.35 |
|
| 1981 |
Henningfield JE, Ator NA, Griffiths RR. Establishment and maintenance of oral ethanol self-administration in the baboon. Drug and Alcohol Dependence. 7: 113-24. PMID 7195797 DOI: 10.1016/0376-8716(81)90025-9 |
0.352 |
|
| Show low-probability matches. |